title: Kinetics of imipenem distribution into the peritoneal fluid of patients with severe peritonitis studied by microdialysis.
abstract: OBJECTIVE
  A microdialysis study of meropenem distribution in the peritoneal fluid of patients with peritonitis has suggested that there is significant peripheral drug degradation. The aims of the present study were to investigate the plasma and peritoneal fluid pharmacokinetics of imipenem, a relatively unstable antibacterial, in patients with severe peritonitis, and to relate measured unbound concentrations to the minimum inhibitory concentrations required for susceptible and intermediately susceptible bacteria.
  
  
  METHODS
  Microdialysis catheters were placed into the peritoneal cavity through peritoneal drains in nine critically patients. Imipenem concentrations in plasma and in peritoneal fluid were analysed using compartmental modelling.
  
  
  RESULTS
  A model that considered elimination from a peripheral compartment described the data and was used to simulate steady-state concentration profiles in plasma and peritoneal fluid during various dosing regimens. Using recommended dosing regimens (500 mg every 6 hours, 1000 mg every 8 hours and 1000 mg every 6 hours), simulated unbound peritoneal fluid concentrations of imipenem in patients with severe peritonitis reached values sufficient for antibacterial effects against susceptible bacteria. However, the adequacy of regimens in patients with severe peritonitis whose infections involve intermediately susceptible bacteria is questionable.
  
  
  CONCLUSIONS
  The results of this study are consistent with those previously observed with meropenem and confirm the usefulness of microdialysis for assessment of peritoneal fluid distribution of antibacterials.
authors.affiliation: Inserm ERI-23, Poitiers, France.
authors.forename: Claire
authors.initials: C
authors.lastname: Dahyot-Fizelier
authors.forename: Sandrine
authors.initials: S
authors.lastname: Lefeuvre
authors.forename: Leila
authors.initials: L
authors.lastname: Laksiri
authors.forename: Sandrine
authors.initials: S
authors.lastname: Marchand
authors.forename: Ronald J
authors.initials: RJ
authors.lastname: Sawchuk
authors.forename: William
authors.initials: W
authors.lastname: Couet
authors.forename: Olivier
authors.initials: O
authors.lastname: Mimoz
mesh_terms: D000368:Aged; D000900:Anti-Bacterial Agents / Q000737:chemistry / Q000493:pharmacokinetics* / Q000627:therapeutic use; D001202:Ascitic Fluid / Q000737:chemistry / Q000187:drug effects / Q000378:metabolism*; D016638:Critical Illness / Q000628:therapy; D005260:Female; D006801:Humans; D015378:Imipenem / Q000737:chemistry / Q000493:pharmacokinetics* / Q000627:therapeutic use; D008297:Male; D017551:Microdialysis / Q000379:methods*; D008875:Middle Aged; D008956:Models, Chemical; D010538:Peritonitis / Q000188:drug therapy / Q000378:metabolism*; D012720:Severity of Illness Index
chemical_list: D000900:Anti-Bacterial Agents; D015378:Imipenem
references.citation: Clin Pharmacol Ther. 2008 Mar;83(3):452-9
references.pmid: 17687272
references.citation: Br J Surg. 1994 Feb;81(2):209-13
references.pmid: 8156338
references.citation: Clin Pharmacokinet. 2008;47(3):181-9
references.pmid: 18307372
references.citation: World J Surg. 2000 Jan;24(1):32-7
references.pmid: 10594200
references.citation: Intensive Care Med. 2003 Apr;29(4):530-8
references.pmid: 12664219
references.citation: Drugs. 1987 Mar;33(3):183-241
references.pmid: 3552595
references.citation: Pharm Res. 1998 Nov;15(11):1673-9
references.pmid: 9833986
references.citation: Antimicrob Agents Chemother. 2008 Apr;52(4):1516-8
references.pmid: 18195055
references.citation: Mayo Clin Proc. 1999 Apr;74(4):420-34
references.pmid: 10221472
references.citation: Antimicrob Agents Chemother. 1992 Jul;36(7):1577-9
references.pmid: 1510457
references.citation: Arch Surg. 1996 Jun;131(6):641-5
references.pmid: 8645072
references.citation: Crit Care Med. 1998 Dec;26(12):2078-86
references.pmid: 9875924
references.citation: Antimicrob Agents Chemother. 2006 Jan;50(1):34-7
references.pmid: 16377663
references.citation: World J Surg. 2004 Feb;28(2):137-41
references.pmid: 14708056
references.citation: Clin Infect Dis. 2003 Oct 15;37(8):997-1005
references.pmid: 14523762
references.citation: Clin Infect Dis. 1997 Jun;24(6):1035-45; quiz 1046-7
references.pmid: 9195055
references.citation: Clin Pharmacokinet. 2000 Sep;39(3):185-201
references.pmid: 11020134
references.citation: Clin Pharmacokinet. 1995 Apr;28(4):275-86
references.pmid: 7648757
references.citation: Epilepsia. 2001 Dec;42(12):1590-3
references.pmid: 11879372